Oral Dose Packaging Market by Material (Plastic, Glass, Metal, Paper & Paperboard), Type (Blister Packs, Bottles, Prefilled Inhalers), Dosage Formulation (Tablets, Capsules), Application (Pharmaceutical, Healthcare), and Region - Global Forecast to 2030

icon1
USD  81.84 BN
MARKET SIZE, 2030
icon2
CAGR 14.5%
(2025-2030)
icon3
215
REPORT PAGES
icon4
138
MARKET TABLES

OVERVIEW

oral-dose-packaging-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The oral dose packaging market is projected to reach USD 81.84 billion by 2030 from USD 41.98 billion in 2025, at a CAGR of 14.5% during the same period. Oral-dose packaging encompasses materials and systems designed to contain, protect, and deliver pharmaceutical products intended for oral administration. These packaging solutions include blister packs, plastic bottles, prefilled inhalers, and other specialized containers that ensure product integrity, patient safety, and ease of use. The market is experiencing significant growth due to rising demand for oral drug delivery systems, which provide ease of use, improved patient compliance, and eliminate the need for sterile conditions. Technological advancements and the introduction of new carriers, such as nanocarriers, micelles, and cyclodextrins, are expected to enhance the therapeutic potential and stability of oral dose packaging.

KEY TAKEAWAYS

  • By Region
    Asia Pacific is projected to register the highest growth rate of 16.5% in the oral-dose packaging market during the forecast period, followed by North America at 13.0% from 2025 to 2030.
  • By Type
    Blister packs dominate the market due to their tamper-evident properties and patient adherence benefits, offering superior protection and ease of use for oral pharmaceutical products.
  • By Application
    The pharmaceutical sector represents the largest application segment, driven by the increasing preference for non-invasive drug delivery methods and the aging population's desire for easy-to-use products.
  • By Material
    Plastic is gaining significant traction as a key packaging material, supported by its convenience and compatibility with diverse drug formulations.
  • Competitive Landscape - Star Players
    Amcor, Gerresheimer, Schott, AptarGroup, and West Pharmaceutical Services were identified as star players in the oral dose packaging market, given their strong market share and extensive product footprint.
  • Competitive Landscape - Startups
    Emerging companies and specialized manufacturers have distinguished themselves by securing strong footholds in sustainable packaging solutions and advanced carrier integration, underscoring their potential as emerging market leaders.

The oral-dose packaging market is expected to maintain a dominant position due to increasing demands in North America and Asia Pacific, driven by technological advancements in packaging features like controlled release rates and the integration of advanced carriers within pharmaceutical packaging.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The oral-dose packaging market is currently experiencing a phase of innovation and rapid adoption. Pharmaceutical companies and healthcare systems across North America, Asia Pacific, and Europe are witnessing advancements in packaging technologies and material science. This progress aligns with emerging trends in patient-centric design, sustainable packaging solutions, and advanced drug delivery systems. In the global market, the use of innovative carriers such as nanocarriers, lipid-based systems, and cyclodextrins is increasing among pharmaceutical manufacturers and contract packaging organizations. These technologies facilitate improved bioavailability, enhanced therapeutic potential, and better stability of oral medications, which promote improved patient outcomes, reduce medication errors, and align with personalized medicine approaches. Governments and regulatory bodies are encouraging the adoption of recyclable materials, the development of smart packaging with tracking capabilities, and public-private research and development programs. These initiatives help ensure product safety, promote environmental sustainability, and support the adoption of automation-friendly, clinically validated packaging platforms tailored to the needs of diverse patient populations.

oral-dose-packaging-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing preference for non-invasive drug delivery methods and growing aging population
  • Advances in drug formulation technologies improving bioavailability through innovative carrier systems
RESTRAINTS
Impact
Level
  • Stringent regulatory frameworks and high production costs requiring error-free manufacturing processes
OPPORTUNITIES
Impact
Level
  • Growing regional trend towards sustainable packaging solutions employing recyclable materials
CHALLENGES
Impact
Level
  • Ensuring packaging compatibility with diverse drug formulations and complex manufacturing requirements

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing preference for non-invasive drug delivery methods and growing aging population

The increasing preference for non-invasive drug delivery methods, combined with the growing aging population, is driving significant adoption of oral-dose packaging solutions. Patients and healthcare providers favor oral medications due to their ease of administration, improved compliance, and reduced need for medical supervision. The aging population particularly benefits from user-friendly packaging designs that facilitate independent medication management and reduce the risk of dosing errors.

Restraint: Stringent regulatory frameworks and high production costs requiring error-free manufacturing processes

Stringent regulatory frameworks and high production costs present significant challenges for oral-dose packaging manufacturers. Regulatory compliance requires extensive testing, validation, and documentation to ensure product safety and efficacy. The need for error-free manufacturing processes, combined with complex quality-control requirements, increases operational costs and extends time-to-market for new packaging solutions across regulatory jurisdictions.

Opportunity: Growing regional trend towards sustainable packaging solutions employing recyclable materials

The growing regional trend towards sustainable packaging solutions presents significant growth opportunities in the oral-dose packaging market. Pharmaceutical companies and packaging manufacturers are increasingly adopting recyclable materials, biodegradable polymers, and reduced-waste designs to minimize environmental impact. This shift aligns with consumer preferences, corporate sustainability goals, and regulatory initiatives promoting circular economy principles in the pharmaceutical industry.

Challenge: Ensuring packaging compatibility with diverse drug formulations and complex manufacturing requirements

Ensuring packaging compatibility with diverse drug formulations remains a key challenge due to the varied chemical properties, stability requirements, and delivery mechanisms of different pharmaceutical products. Manufacturers must invest in material science research, compatibility testing, and specialized production capabilities to develop packaging solutions that maintain drug integrity, prevent degradation, and support optimal therapeutic performance across a wide range of oral medications.

ORAL DOSE PACKAGING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Supplies blister packs and plastic bottles for oral pharmaceutical products, providing tamper-evident packaging solutions with enhanced patient compliance features for leading pharmaceutical companies globally. Ensures product integrity, improves patient adherence, supports brand protection, and enables cost-efficient, large-scale manufacturing with sustainable materials.
Provides medical-grade plastic bottles, blister packaging systems, and specialized containers for oral solid dose medications across pharmaceutical manufacturers in North America, Europe, and Asia Pacific markets. Delivers high barrier protection, ensures regulatory compliance, supports diverse drug formulations, and enables reliable supply chain performance with advanced quality control.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The oral dose packaging market is a collaborative ecosystem where packaging material suppliers, pharmaceutical manufacturers, contract packaging organizations, technology providers, and healthcare professionals work together to develop and implement packaging solutions in the pharmaceutical sector. Companies in the market supply a variety of packaging formats, including blister packs, plastic bottles, prefilled inhalers, and specialized containers designed for oral medications. Contract development and manufacturing organizations, contract packaging organizations, and research institutions support the development, testing, and scale-up process for these packaging solutions. Technology providers contribute innovations in smart packaging, sustainable materials, and advanced barrier systems. Ultimately, pharmaceutical companies and healthcare institutions utilize the developed packaging solutions, benefiting from supportive regulations, quality standards, and patient safety requirements.

oral-dose-packaging-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

oral-dose-packaging-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Oral Dose Packaging Market, by Type

Blister packs dominated the market in 2025, serving as the backbone of oral pharmaceutical packaging used daily in pharmacies and healthcare facilities. This is due to their tamper-evident properties, unit-dose convenience, and proven performance in protecting medications from moisture and contamination, making them preferred for tablets, capsules, and other solid oral dosage forms.

Oral Dose Packaging Market, by Application

The pharmaceutical sector accounted for the largest share of the oral dose packaging market. The increasing demand for oral medications has propelled this segment to the forefront globally. Factors such as an aging population, growing prevalence of chronic diseases requiring long-term medication, rising healthcare expenditures, and the preference for non-invasive treatment options are driving the demand for blister packs, plastic bottles, and other oral-dose packaging solutions.

REGION

Asia Pacific to be the fastest-growing regional market during the forecast period

Asia Pacific is the fastest-growing region in the oral-dose packaging market, driven by its rapidly expanding pharmaceutical industry, rising healthcare expenditures, and strong demand in populous nations such as China and India. The region is experiencing rising pharmaceutical sales, a growing patient population, and increased production of generic and branded medications. Additionally, significant investment in pharmaceutical manufacturing infrastructure, combined with favorable government policies supporting local production and healthcare access, is facilitating the swift adoption of advanced oral-dose packaging solutions across the region.

oral-dose-packaging-market Region

ORAL DOSE PACKAGING MARKET: COMPANY EVALUATION MATRIX

Amcor, recognized as a leading player in the oral dose packaging market, offers a diverse portfolio that includes blister packs, plastic bottles, and sustainable packaging solutions for pharmaceutical applications. The company boasts a strong manufacturing presence across multiple regions and collaborates with pharmaceutical companies and contract packaging organizations in North America, Europe, and Asia Pacific. Another significant player in the market is Gerresheimer, identified as a key competitor. The company is strengthening its position by introducing advanced packaging systems, specialized containers, and innovative materials designed for use in oral solid dose, liquid, and specialty pharmaceutical products.

oral-dose-packaging-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 41.98 Billion
Market Size in 2030 (Value) USD 81.84 Billion
Growth Rate CAGR of 14.5% from 2025 to 2030
Years Considered 2023–2030
Base Year 2025
Forecast Period 2025–2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • Material (Plastic, Metal, Glass, Paper & Paperboard)
  • Type (Blister Packs, Bottles, Prefilled Inhalers, Sachets, Stick Packs)
  • Dosage Formulation (Tablets, Capsules, Liquid Dose, Powders)
  • Application (Pharmaceutical, Healthcare, Clinical)
Regions Covered Asia Pacific, North America, Europe, South America, Middle East & Africa

WHAT IS IN IT FOR YOU: ORAL DOSE PACKAGING MARKET REPORT CONTENT GUIDE

oral-dose-packaging-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Understanding demand patterns for oral dose packaging across global pharmaceutical markets Assessed packaging format preferences and adoption trends across key regions, including North America, Asia Pacific, and Europe, highlighting differences in blister pack versus bottle usage, sustainable material adoption, and smart packaging integration across generic and branded pharmaceutical segments Helps clients align product portfolios with region-specific regulatory requirements, patient preferences, and pharmaceutical industry trends
Identifying sustainable packaging material suppliers and technology providers Mapped regional suppliers of recyclable materials, biodegradable polymers, and advanced barrier systems across North America, Europe, and Asia Pacific, with insights into material innovation, contract packaging capabilities, and pharmaceutical-grade certification standards Supports sustainability strategies, reduces environmental impact, improves brand positioning, and accelerates the development of eco-friendly packaging solutions

RECENT DEVELOPMENTS

  • 2024 : Amcor signed a significant supply contract with a leading pharmaceutical company to provide sustainable packaging solutions, reinforcing the industry trend towards recyclable and environmentally friendly packaging materials.
  • 2023 : West Pharmaceutical Services formed a strategic partnership to enhance its injectable packaging solutions, expand its capabilities in pharmaceutical delivery systems, and strengthen its position in the broader pharmaceutical packaging market.
  • 2022 : Catalent, Inc. expanded its capabilities through the acquisition of Bettera Holdings for USD 1 billion, significantly strengthening its position in pharmaceutical development and manufacturing services, including packaging solutions.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
 
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.2.3
TRENDS IN PACKAGING INDUSTRY
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND, BY TYPE (2022–2025)
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF ORAL DOSE MATERIAL, BY KEY PLAYER, (2022–2025)
 
 
 
 
 
5.5.3
AVERAGE SELLING PRICE TREND, BY REGION (2022–2025)
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 390461)
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 390461)
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – ORAL DOSE PACKAGING MARKET
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
6.1.1
SMART ORAL DOSE PACKAGING
 
 
 
 
 
6.1.2
SUSTAINABLE HIGH-BARRIER MATERIALS
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
6.2.1
HIGH-SPEED PACKAGING AUTOMATION & ROBOTICS
 
 
 
 
 
6.2.2
UNIT-DOSE & ADHERENCE-ORIENTED PACKAGING FORMATS
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
6.3.1
ADVANCED PRINTING & SERIALIZATION TECHNOLOGIES
 
 
 
 
 
6.3.2
MODIFIED ATMOSPHERE & ACTIVE PACKAGING CONCEPTS
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON ORAL DOSE PACKAGING MARKET
 
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
6.6.2
BEST PRACTICES IN ORAL DOSE PACKAGING MANUFACTURE
 
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN ORAL DOSE PACKAGING MARKET
 
 
 
 
 
6.6.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT AI IN ORAL DOSE PACKAGING MARKET
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
INTRODUCTION
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND EVALUATION CRITERIA
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
9
ORAL DOSE PACKAGING MARKET, BY MATERIAL (MARKET SIZE & FORECAST TO 2030 – IN VALUE [USD MILLION] & VOLUME [KILOTON])
 
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY MATERIALS, MARKET POTENTIAL, AND DEMAND PATTERNS
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
PLASTIC
 
 
 
 
 
9.3
METAL
 
 
 
 
 
9.3
GLASS
 
 
 
 
 
9.3
PAPER & PAPERBOARD
 
 
 
 
10
ORAL DOSE PACKAGING MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2030 – IN VALUE [USD MILLION] & VOLUME [KILOTON])
 
 
 
 
 
 
ANALYSIS OF REQUIREMENT OF ORAL DOSE PACKAGING IN VARIOUS TYPES
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
10.2
BOTTLES
 
 
 
 
 
10.3
BLISTER PACKS
 
 
 
 
 
10.4
PREFILLED INHALERS
 
 
 
 
 
10.5
SACHETS
 
 
 
 
 
10.6
STICK PACKS
 
 
 
 
 
10.7
OTHER TYPES
 
 
 
 
11
ORAL DOSE PACKAGING MARKET, BY DOSAGE FORMULATION (MARKET SIZE & FORECAST TO 2030 – IN VALUE [USD MILLION] & VOLUME [KILOTON])
 
 
 
 
 
 
DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING ORAL DOSE PACKAGING ADOPTION IN DIVERSE FORMULATIONS
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
TABLETS
 
 
 
 
 
11.3
CAPSULES
 
 
 
 
 
11.4
LIQUID DOSES
 
 
 
 
 
11.5
POWDERS
 
 
 
 
12
ORAL DOSE PACKAGING MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2030 – IN VALUE [USD MILLION] & VOLUME [KILOTON])
 
 
 
 
 
 
DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING ORAL DOSE PACKAGING ADOPTION IN DIVERSE APPLICATIONS
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
PHARMACEUTICAL
 
 
 
 
 
12.3
HEALTHCARE
 
 
 
 
 
12.4
CLINICAL
 
 
 
 
 
12.5
OTHER APPLICATIONS
 
 
 
 
13
ORAL DOSE PACKAGING MARKET, BY REGION (MARKET SIZE & FORECAST TO 2030 – IN VALUE [USD MILLION] & VOLUME [KILOTON])
 
 
 
 
 
 
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
 
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
13.2
ASIA PACIFIC
 
 
 
 
 
 
13.2.1
CHINA
 
 
 
 
 
13.2.2
JAPAN
 
 
 
 
 
13.2.3
INDIA
 
 
 
 
 
13.2.4
SOUTH KOREA
 
 
 
 
 
13.2.5
REST OF ASIA PACIFIC
 
 
 
 
13.3
NORTH AMERICA
 
 
 
 
 
 
13.3.1
US
 
 
 
 
 
13.3.2
CANADA
 
 
 
 
 
13.3.3
MEXICO
 
 
 
 
13.4
EUROPE
 
 
 
 
 
 
13.4.1
GERMANY
 
 
 
 
 
13.4.2
FRANCE
 
 
 
 
 
13.4.3
UK
 
 
 
 
 
13.4.4
ITALY
 
 
 
 
 
13.4.5
SPAIN
 
 
 
 
 
13.4.6
REST OF EUROPE
 
 
 
 
13.5
SOUTH AMERICA
 
 
 
 
 
 
13.5.1
BRAZIL
 
 
 
 
 
13.5.2
ARGENTINA
 
 
 
 
 
13.5.3
REST OF SOUTH AMERICA
 
 
 
 
13.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
13.6.1
GCC COUNTRIES
 
 
 
 
 
 
13.6.1.1
SAUDI ARABIA
 
 
 
 
 
13.6.1.2
REST OF GCC COUNTRIES
 
 
 
 
13.6.2
SOUTH AFRICA
 
 
 
 
 
13.6.3
REST OF MIDDLE EAST & AFRICA
 
 
 
14
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
 
14.1
OVERVIEW
 
 
 
 
 
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN (2021–2025)
 
 
 
 
 
14.3
REVENUE ANALYSIS (2022–2024)
 
 
 
 
 
 
14.4
MARKET SHARE ANALYSIS (2024)
 
 
 
 
 
 
14.5
PRODUCT COMPARISON
 
 
 
 
 
 
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
 
14.6.1
STARS
 
 
 
 
 
14.6.2
EMERGING LEADERS
 
 
 
 
 
14.6.3
PERVASIVE PLAYERS
 
 
 
 
 
14.6.4
PARTICIPANTS
 
 
 
 
 
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
14.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
14.6.5.2
REGION FOOTPRINT
 
 
 
 
 
14.6.5.3
MATERIAL FOOTPRINT
 
 
 
 
 
14.6.5.4
TYPE FOOTPRINT
 
 
 
 
 
14.6.5.5
DOSAGE FORMULATION FOOTPRINT
 
 
 
 
 
14.6.5.6
APPLICATION FOOTPRINT
 
 
 
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
 
14.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
14.7.2
RESPONSIVE COMPANIES
 
 
 
 
 
14.7.3
DYNAMIC COMPANIES
 
 
 
 
 
14.7.4
STARTING BLOCKS
 
 
 
 
 
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
 
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
14.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
14.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
14.9.1
PRODUCT LAUNCHES
 
 
 
 
 
14.9.2
DEALS
 
 
 
 
 
14.9.3
EXPANSIONS
 
 
 
15
COMPANY PROFILES
 
 
 
 
 
 
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN ORAL DOSE PACKAGING MARKET LANDSCAPE
 
 
 
 
 
 
15.1
KEY PLAYERS
 
 
 
 
 
 
15.1.1
AMCOR
 
 
 
 
 
 
15.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.1.4
MNM VIEW
 
 
 
 
 
 
15.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
15.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
15.1.2
GERRESHEIMER AG
 
 
 
 
 
 
15.1.2.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.2.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.2.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.2.4
MNM VIEW
 
 
 
 
15.1.3
CONSTANTIA FLEXIBLES
 
 
 
 
 
 
15.1.3.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.3.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.3.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.3.4
MNM VIEW
 
 
 
 
15.1.4
WEST PHARMACEUTICAL SERVICES
 
 
 
 
 
 
15.1.4.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.4.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.4.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.4.4
MNM VIEW
 
 
 
 
15.1.5
APTARGROUP
 
 
 
 
 
 
15.1.5.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.5.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.5.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.5.4
MNM VIEW
 
 
 
 
15.1.6
SCHOTT
 
 
 
 
 
 
15.1.6.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.6.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.7.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.6.4
MNM VIEW
 
 
 
 
15.1.7
CATALENT
 
 
 
 
 
 
15.1.7.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.7.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.7.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.7.4
MNM VIEW
 
 
 
 
15.1.8
CCL INDUSTRIES
 
 
 
 
 
 
15.1.8.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.8.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.8.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.8.4
MNM VIEW
 
 
 
 
15.1.9
NIPRO CORPORATION
 
 
 
 
 
 
15.1.9.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.9.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.9.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.9.4
MNM VIEW
 
 
 
 
15.1.10
KLÖCKNER PENTAPLAST
 
 
 
 
 
 
15.1.10.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.10.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.10.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.10.4
MNM VIEW
 
 
 
15.2
OTHER PLAYERS
 
 
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
 
16.1
RESEARCH DATA
 
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
 
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
16.1.1.2
LIST OF KEY SECONDARY SOURCES
 
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
 
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
16.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
16.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
16.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
16.2.2
TOP-DOWN APPROACH
 
 
 
 
 
16.2.3
MARKET SIZE CALCULATION FOR BASE YEAR
 
 
 
 
16.3
MARKET FORECAST APPROACH
 
 
 
 
 
 
16.3.1
SUPPLY SIDE
 
 
 
 
 
16.3.2
DEMAND SIDE
 
 
 
 
16.4
DATA TRIANGULATION
 
 
 
 
 
16.5
FACTOR ANALYSIS
 
 
 
 
 
16.6
RESEARCH ASSUMPTIONS AND LIMITATIONS
 
 
 
 
 
16.7
RISK ASSESSMENT
 
 
 
 
17
APPENDIX
 
 
 
 
 
 
17.1
DISCUSSION GUIDE
 
 
 
 
 
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
17.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 
 

Methodology

The study involved four major activities to estimate the current size of the Oral Dose Packaging Market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the Oral Dose Packaging Market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the Oral Dose Packaging Market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the Oral Dose Packaging Market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the size of the Oral Dose Packaging Market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

Oral Dose Packaging Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).

Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.

Stakeholders

  • Pharmaceutical packaging manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the Oral Dose Packaging Market, based  on type, packaging type, drug delivery, raw material, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the Oral Dose Packaging Market
  • To provide the impact of AI/Gen AI on the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to client-specific needs.

The following customization options are available for the Oral Dose Packaging Market report:

Product Analysis

  • A product matrix that gives a detailed comparison of the product portfolio of each company

Geographic Analysis as per Feasibility

  • A further breakdown of the Oral Dose Packaging Market for additional countries

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Oral Dose Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Oral Dose Packaging Market

Turn Research into Strategy in Minutes. Generate 15+ consulting-grade intelligence outputs instantly
Interactive dashboards | Proprietary market intelligence
Try GrowthIQ →
DMCA.com Protection Status